Biogen Inc.
BIIB · Healthcare · · USDFahodi Score BUY Long-term (Investment)
66
/ 100
Technical
75
Trend & RS
96
Momentum
80
Fundamental
85
Macro
24
Liquidity
36
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 95.6 | 10% |
| Momentum | 79.7 | 5% |
| Fundamental | 85.4 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 35.6 | 20% |
Trade Setup
| Entry | 242.57 |
| Stop Loss | 227.01 (6.4%) |
| Target 1 (1:1) | 258.13 (+6.4%) |
| Target 2 (2:1) | 273.69 (+12.8%) |
| ATR(14) | 7.78 (3.2%) |
| Risk per Share | 15.56 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 48.8 | -0.05 | |
| Momentum | 79.7 | +1.19 | |
| Quality | 30.6 | -0.78 | |
| Composite | 53.0 | ||
Quality Scores
Piotroski F-Score
7
/9 —
Strong
✓
✓
✗
✗
✓
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
4.65
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Fair Value
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 105.8 | 22.0 | +381% above |
| P/B Ratio | 1.9 | 4.0 | Below |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
41.00
vs
Market Price
244.33
Upside
-83.2%
| Margin of Safety | -495.9% |
| Stage 1 PV (5yr FCF) | 1,427,197,017 |
| Terminal Value PV | 4,633,289,891 |
| Total Enterprise Value | 6,060,486,908 |
Assumptions
| Base FCF | 273,171,772 |
| Growth Rate (5yr) | 10.6% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
43.23%
Full Kelly
21.61%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 66/100. Estimated win rate 60%, avg win 9.0%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
52.27
RSI(14)
5.7095
MACD
Relative Strength (RS) IMPROVING
88
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+22.1% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | Near 3-month high 2d since high |
| Sector Outperformance | +4.3% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 52.27 | NEUTRAL |
| Macd | 5.7095 | BEARISH |
| Ma Cross | 229.89 / 203.15 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.01x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 258.78 |
| Bollinger Upper | 261.14 |
| SMA(200) | 203.15 |
| SMA(50) | 229.89 |
| SMA(20) | 243.62 |
| Current Price | 244.33 |
| Bollinger Lower | 226.1 |
| 52-Week Low | 151.83 |
| ATR(14) | 7.78 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.89x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.81x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.03x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 0.93x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.01x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 249.39 | Above Kijun |
| Kijun-sen (26) | 237.25 | Base line |
| Senkou A | 243.32 | Leading span A |
| Senkou B | 233.85 | Leading span B |
| Cloud | 233.85 – 243.32 | Bullish (Green) |
| Price vs Cloud | 242.57 | Inside Cloud |
| Chikou Span | 219.88 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH
BB: 226.1 – 261.14 | KC: 231.41 – 255.83
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Hidden Bullish | RSI | 26 |
Anchored VWAP
VWAP: 193.71
Anchor: 2025-11-07 (52w Low)
ABOVE AVWAP
+25.2%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/BIIB
Valuation
| Metric | Value |
|---|---|
| Market Cap | 36.12B |
| P/E (TTM) | 105.77 |
| Forward P/E | N/A |
| P/B | 1.91 |
| EPS | 2.31 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 10.6% |
| Profit Margin | 3.4% |
| ROE | 1.9% |
| Debt/Equity | 41.23 |
| Current Ratio | 1.95 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 0.09 |
Trading Data
244.33
Open
244.33
Day High
244.33
Day Low
32.5K
Volume (0.0x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)